WO2023079137 - NEUTRALIZING ANTI-SARS-COV-2 HUMAN ANTIBODIES
National phase entry is expected:
Publication Number
WO/2023/079137
Publication Date
11.05.2023
International Application No.
PCT/EP2022/080965
International Filing Date
07.11.2022
Title **
[English]
NEUTRALIZING ANTI-SARS-COV-2 HUMAN ANTIBODIES
[French]
ANTICORPS HUMAINS NEUTRALISANT ANTI-SARS-COV-2
Applicants **
KATHOLIEKE UNIVERSITEIT LEUVEN
KU Leuven R & D Waaistraat 6 - box 5105
3000 Leuven, BE
VIB VZW
Rijvisschestraat 120
9052 Gent, BE
UNIVERSITEIT GENT
Sint-Pietersnieuwstraat 25
9000 Gent, BE
Inventors
GEUKENS, Nick
Gooreinde 67
2260 Westerlo, BE
DECLERCK, Paul
Lemingstraat 9
3210 Linden, BE
IMBRECHTS, Maya
Zwaluwlaan 31
3110 Rotselaar, BE
AMPOFO, Louanne
Groenveldstraat 59 bus 0201
3001 Heverlee, BE
MAES, Wim
Engelandlaan 15
8550 Zwevegem, BE
NEYTS, Johan
Heidebergstraat 278
3010 Kessel-Lo, BE
ABDELNABI, Rana
Heilige-Geeststraat 6 bus 0103
3000 Leuven, BE
EECKHAUT, Hannah
Rijvisschestraat 120
9052 Gent, BE
CALLEWAERT, Nico
Rijvisschestraat 120
9052 Gent, BE
FIJALKOWSKA, Daria
Rijvisschestraat 120
9052 Gent, BE
Priority Data
21206787.0
05.11.2021
EP
21216594.8
21.12.2021
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1575 | |
| EPO | Filing, Examination | 5797 | |
| Japan | Filing | 595 | |
| South Korea | Filing | 607 | |
| USA | Filing, Examination | 2710 |

Total: 11284 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
of less than 300 pM.[French]
inférieur à 300 pM.